Skip to main content
HR 2400 111th Congress House Health Advisory bodies Department of Health and Human Services Drug therapy Executive agency funding and structure Government information and archives Health information and medical records Health programs administration and funding Infectious and parasitic diseases Medical research Prescription drugs Research administration and funding Veterinary medicine and animal diseases

Strategies to Address Antimicrobial Resistance Act

Introduced: May 13, 2009 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 14, 2009
Referred to the Subcommittee on Health.
May 13, 2009
Referred to the House Committee on Energy and Commerce.
May 13, 2009
Sponsor introductory remarks on measure. (CR E1142-1143)
May 13, 2009
Introduced in House
 Plain-English summary Congressional Research Service

Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to establish the Antimicrobial Resistance Office. Requires the Secretary to establish the Public Health Antimicrobial Advisory Board to advise the Director of the Office (Director).

Requires the Director to update the Public Health Action Plan to Combat Antimicrobial Resistance within 18 months.

Requires the Secretary, acting through the Director, the Director of the Centers for Disease Control and Prevention (CDC), and the Director of the National Institutes of Health (NIH), to: (1) develop an antimicrobial resistance strategic research plan; and (2) establish at least ten Antimicrobial Resistance Surveillance and Research Network sites.

Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary to require each sponsor of an approved human antimicrobial drug product sold or distributed in the United States to submit antimicrobial drug sales and distribution data.

Requires that an application for a new animal drug contain information to ensure that reported data is comparable and reliable. Requires (currently, permits) the Secretary to share information reported in a new animal drug application with the Antimicrobial Resistance Task Force.

Sets forth provisions for the Secretary to secure reliable and comparable animal and human antimicrobial drug consumption data.

Requires the Under Secretary for Health of the Department of Veterans Affairs (VA), the Administrator of the Centers for Medicare & Medicaid Services, and the Director to work together to identify and report upon interventions that prevent and control the development of antimicrobial resistance.

What's happening now May 14, 2009

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1